|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Silzle, Tobias 
ORCID: https://orcid.org/0000-0001-6859-3090; Blum, Sabine; Kasprzak, Annika ORCID: https://orcid.org/0000-0001-7642-6751; Nachtkamp, Kathrin; Rudelius, Martina; Hildebrandt, Barbara; Götze, Katharina S. ORCID: https://orcid.org/0000-0002-6276-8002; Gattermann, Norbert; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127 und Germing, Ulrich
(2023):
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score.
In: Cancers, Bd. 15, Nr. 14, 3572
[PDF, 1MB]
ORCID: https://orcid.org/0000-0001-6859-3090; Blum, Sabine; Kasprzak, Annika ORCID: https://orcid.org/0000-0001-7642-6751; Nachtkamp, Kathrin; Rudelius, Martina; Hildebrandt, Barbara; Götze, Katharina S. ORCID: https://orcid.org/0000-0002-6276-8002; Gattermann, Norbert; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127 und Germing, Ulrich
(2023):
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score.
In: Cancers, Bd. 15, Nr. 14, 3572
[PDF, 1MB]
Müller‐Thomas, Catharina; Heider, Michael; Piontek, Guido; Schlensog, Martin; Bassermann, Florian; Kirchner, Thomas; Germing, Ulrich; Götze, Katharina S. und Rudelius, Martina
(2020):
Prognostic value of indoleamine 2,3 dioxygenase in patients with higher‐risk myelodysplastic syndromes treated with azacytidine.
In: British Journal of Haematology, Bd. 190, Nr. 3: S. 361-370
[PDF, 6MB]
Jilg, Stefanie; Hauch, Richard T.; Kauschinger, Johanna; Buschhorn, Lars; Odinius, Timo O.; Dill, Veronika; Müller-Thomas, Catharina; Herold, Tobias; Prodinger, Peter M.; Schmidt, Burkhard; Hempel, Dirk; Bassermann, Florian; Peschel, Christian; Götze, Katharina S.; Hoeckendorf, Ulrike; Haferlach, Torsten und Jost, Philipp J.
(2019):
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose.
In: Experimental Hematology & Oncology, Bd. 8, 9
Müller-Thomas, Catharina; Tuechler, Heinz; Rudelius, Martina; Schneider, Heike; Pfefferkorn, Sabrina und Götze, Katharina S.
(2019):
Serum Vitamin D Levels in Patients with Myelodysplastic Syndromes: A Retrospective Single-Center Analysis.
In: Acta Haematologica, Bd. 141, Nr. 4: S. 225-231
Kuendgen, Andrea; Müller-Thomas, Catharina; Lauseker, Michael; Haferlach, Torsten; Urbaniak, Petra; Schroeder, Thomas; Brings, Carolin; Wulfert, Michael; Meggendorfer, Manja; Hildebrandt, Barbara; Betz, Beate; Royer-Pokora, Brigitte; Gattermann, Norbert; Haas, Rainer; Germing, Ulrich und Götze, Katharina S.
(2018):
Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature.
In: Oncotarget, Bd. 9, Nr. 45: S. 27882-27894
Wenk, Catharina; Garz, Anne-Kathrin; Grath, Sonja; Huberle, Christina; Witham, Denis; Weickert, Marie; Malinverni, Roberto; Niggemeyer, Julia; Kyncl, Michele; Hecker, Judith; Pagel, Charlotta; Mulholland, Christopher B.; Müller-Thomas, Catharina; Leonhardt, Heinrich; Bassermann, Florian; Oostendorp, Robert A. J.; Metzeler, Klaus H.; Buschbeck, Marcus und Götze, Katharina S.
(2018):
Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis.
In: Blood Advances, Bd. 2, Nr. 23: S. 3447-3461
Schreck, Christina; Istvanffy, Rouzanna; Ziegenhain, Christoph; Sippenauer, Theresa; Ruf, Franziska; Henkel, Lynette; Gärtner, Florian; Vieth, Beate; Florian, M. Carolina; Mende, Nicole; Taubenberger, Anna; Prendergast, Aine; Wagner, Alina; Pagel, Charlotta; Grziwok, Sandra; Götze, Katharina S.; Guck, Jochen; Dean, Douglas C.; Massberg, Steffen; Essers, Marieke; Waskow, Claudia; Geiger, Hartmut; Schiemann, Mathias; Peschel, Christian; Enard, Wolfgang und Oostendorp, Robert A. J.
(2017):
Niche WNT5A regulates the actin cytoskeleton during regeneration of hematopoietic stem cells.
In: Journal of Experimental Medicine, Bd. 214, Nr. 1: S. 165-181
Eichner, Ruth; Heider, Michael; Fernández-Sáiz, Vanesa; Bebber, Frauke van; Garz, Anne-Kathrin; Lemeer, Simone; Rudelius, Martina; Targosz, Bianca-Sabrina; Jacobs, Laura; Knorn, Anna-Maria; Slawska, Jolanta; Platzbecker, Uwe; Germing, Ulrich; Langer, Christian; Knop, Stefan; Einsele, Herrmann; Peschel, Christian; Haass, Christian ORCID: https://orcid.org/0000-0002-4869-1627; Keller, Ulrich; Schmid, Bettina; Götze, Katharina S.; Kuster, Bernhard und Bassermann, Florian
(2016):
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.
In: Nature Medicine, Bd. 22, Nr. 7: S. 735-743
ORCID: https://orcid.org/0000-0002-4869-1627; Keller, Ulrich; Schmid, Bettina; Götze, Katharina S.; Kuster, Bernhard und Bassermann, Florian
(2016):
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.
In: Nature Medicine, Bd. 22, Nr. 7: S. 735-743